TY  - JOUR
T1  - Error in financial disclosure in: Conjugated equine estrogens and coronary heart disease: the women's health initiative
Y1  - 2006/04/10
N1  - 10.1001/archinte.166.7.759
JO  - Archives of Internal Medicine
SP  - 759
EP  - 759
VL  - 166
IS  - 7
N2  - 
Error in Financial Disclosure. In the Original Investigation by Hsia et al titled “Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative,” published in the February 13 issue of the ARCHIVES (2006;166:357-365), an error occurred in the financial disclosure. It should have appeared as follows: “Dr Langer received honoraria from Solvay Pharmaceuticals (Houston, Tex) and served as a consultant for Berlex (Montville, NJ), Monarch-King Pharmaceuticals (Bristol, Tenn), and Wyeth Pharmaceuticals (Collegeville, Pa). Dr Prentice received an honorarium from Wyeth Pharmaceuticals in 2004.” This correction was made previously to online versions of this article.

SN  - 0003-9926
M3  - doi: 10.1001/archinte.166.7.759
UR  - http://dx.doi.org/10.1001/archinte.166.7.759
ER  -